Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Tick-borne Encephalitis Virus Envelope Glycoprotein (None)
- Target
- None
- Molecular classification
- Viral protein, Envelope glycoprotein
01
Overview
The envelope glycoprotein (E protein) of the tick-borne encephalitis virus (TBEV) is the major surface protein and a critical component of the mature virion. It plays essential roles in viral entry, membrane fusion, receptor binding, and induction of protective immunity. The E glycoprotein consists of 496 amino acid residues organized into four domains: Domain I (central β-barrel), Domain II (elongated/fusion loop/dimerization interface), Domain III (Ig-like fold), and the Stem-anchor region. It is glycosylated at Asn154. The E protein mediates attachment to host cell receptors and triggers low-pH-induced fusion between viral and endosomal membranes. It undergoes conformational changes ("virus breathing") influencing antibody accessibility and is a major target for neutralizing antibodies.
02
Mechanism of action
Viral entry inhibition (potential target for antivirals)
03
Biological functions
Receptor bindingMembrane fusionViral entryInduction of protective immunity
04
Disease associations
InfectionTick-borne encephalitis
05
Safety considerations
Potential for off-target effects if targeting conserved regionsRisk of resistance development
Beyond the preview
Go deeper on Tick-borne Encephalitis Virus Envelope Glycoprotein (None).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Tick-borne Encephalitis Virus Envelope Glycoprotein (None).